Requip tablet prices and pack options

Requip choices at a glance

Requip is a brand of ropinirole, a dopamine agonist supplied as an oral tablet for Parkinson's disease and moderate-to-severe idiopathic restless legs syndrome. In our catalogue, we list Requip tablets in 0.25 mg, 0.5 mg, 1 mg and 2 mg strengths, with several package quantities available for each strength. The practical choice is therefore not simply which medicine to order. You need to match the exact strength directed by your prescriber, then compare the package quantities and current prices we offer for that strength.

Strength and quantity answer different questions. Strength determines how much ropinirole each tablet contains, while package quantity determines how many tablets are supplied. A lower unit price may be relevant, but it should not override a recent dose change, a short expected treatment period, storage requirements or the expiry date. This guide explains how to compare our options without turning a price comparison into a dosing decision.

What pack options and prices do we offer?

Our package-value comparison brings together the current quantities, exact prices, price per tablet and relative value available from us. Availability differs by strength, so compare options only after selecting the strength stated in your current treatment instructions. The price comparison image also shows the current figures for this page; we do not use external pharmacy prices or unsupported market averages.

A larger package may reduce the price per tablet, but that does not automatically make it the appropriate choice. Consider whether the quantity is likely to be used during the treatment period your prescriber expects, particularly when ropinirole is being started, restarted or adjusted. If the dose is still changing, a smaller quantity may limit unused tablets even when its unit price is higher.

Strength, form and quantity decisions

All options in this listing are oral Requip tablets containing ropinirole. They are not patches, prolonged-release tablets, injections or another pharmaceutical form. The four listed strengths contain different amounts of the same active ingredient, but a customer should not substitute one strength for another or combine tablets to make a prescribed dose unless a prescriber or pharmacist has confirmed that approach.

Ropinirole is normally introduced at a low dose and adjusted gradually, but the dosing schedule and titration process differ between Parkinson's disease and restless legs syndrome. A package that suits established treatment may therefore be less suitable during early titration. The following checks help keep the financial comparison separate from the medical decision.

Do not change to another strength solely because it is available in a preferred package quantity. If the option written on your prescription or treatment plan is not clear, confirm it with the prescriber or a pharmacist before ordering.

Requip, generic ropinirole and alternatives

Requip is a branded ropinirole medicine. Generic ropinirole tablets may also be available in some markets, but this price and package comparison relates to the specific Requip listing in our catalogue. A generic product with the same active ingredient, strength, dosage form and route is expected to meet the applicable quality and bioequivalence requirements, although the manufacturer, inactive ingredients, tablet appearance and available package sizes may differ. Anyone advised to maintain a particular brand should check before changing products.

Other medicines that may be considered for Parkinson's disease or restless legs syndrome include pramipexole, rotigotine, levodopa/carbidopa, rasagiline, selegiline, Amantadine, apomorphine and gabapentin enacarbil. They differ in active ingredient, drug class, dosage form or clinical role and are not direct, self-selected substitutes for Requip. A change to another medicine should be directed by a prescriber after considering symptoms, response, adverse effects and other treatment.

What is Requip used for?

Ropinirole tablets have two established adult uses. In Parkinson's disease, ropinirole can help manage motor symptoms by stimulating dopamine receptors. It may be prescribed alone in earlier treatment or used with levodopa when additional symptom control is needed. Its place in treatment depends on the person's symptoms, response and adverse effects.

Ropinirole is also used for moderate-to-severe idiopathic restless legs syndrome, particularly when symptoms are frequent or significantly disruptive. Treatment should be reviewed because symptoms can sometimes begin earlier in the day, become more intense or spread to other parts of the body. This is known as augmentation and should be discussed with the prescriber rather than managed by increasing the dose without advice.

Requip is intended for adults. Australian product information does not recommend ropinirole for people under 18 because safety and effectiveness have not been established in that age group.

Mechanism and practical use

Ropinirole is a non-ergot dopamine agonist. It activates dopamine receptors in the brain, helping compensate for reduced dopamine activity in Parkinson's disease. Dopamine signalling is also involved in its effect on restless legs syndrome. The response varies between individuals, which is why treatment is normally started cautiously and adjusted according to clinical response and tolerability.

• Take Requip at the times and in the dose directed by the prescriber. Dosing schedules are not the same for Parkinson's disease and restless legs syndrome.
• Swallow the tablet with water. Follow the product information or pharmacist's directions rather than crushing, splitting or combining tablets without confirmation.
• Requip may be taken with food, which can help reduce nausea for some people.
• If a dose is missed, follow the instructions supplied with the medicine or ask a pharmacist. Do not automatically double the next dose.
• Do not stop ropinirole suddenly unless urgent medical advice directs otherwise. Abrupt reduction or withdrawal can cause significant symptoms, so a prescriber will usually plan dose changes gradually.

These points are general information and do not determine an individual dose. The labelled strength and the prescriber's instructions remain more important than package price or convenience.

Safety and interaction checks

Common adverse effects of ropinirole can include nausea, dizziness, sleepiness and headache. Some people experience low blood pressure on standing, faintness, hallucinations or confusion. The risk and significance of these effects can vary with the dose, age, other medicines and the condition being treated.

• Ropinirole can cause marked drowsiness or sudden sleep onset, sometimes without warning. Anyone affected must not drive, operate machinery or undertake an activity in which reduced alertness could cause serious harm.
• Dopamine agonists can be associated with impulse-control problems such as compulsive gambling, uncontrolled spending, binge eating or unusually increased sexual urges. New or difficult-to-control behaviour should be reported promptly to the prescriber.
• Ropinirole should not be used during pregnancy unless the expected benefit outweighs the potential risk to the fetus. It is not recommended while breastfeeding because it may inhibit milk production.
• People with a known allergy to ropinirole or another ingredient in the tablet should not take the product.
• Dopamine-blocking medicines, including some antipsychotics and anti-nausea medicines, may reduce ropinirole's effect. CYP1A2 inhibitors, including medicines such as ciprofloxacin and fluvoxamine, can increase ropinirole exposure.
• Starting or stopping smoking can alter ropinirole levels because tobacco smoke affects CYP1A2 activity. A prescriber should be told about a substantial change in smoking habits.

Before starting or changing treatment, provide the prescriber or pharmacist with a complete list of prescription medicines, non-prescription products and supplements. Seek medical advice for severe sleepiness, fainting, hallucinations, uncontrolled behaviour or a marked worsening or earlier onset of restless legs symptoms.

Store the tablets at 20°C to 25°C; brief excursions from 15°C to 30°C are permitted. Keep them in the original tightly closed container and protect them from light and moisture. Always follow the storage directions printed on the supplied pack if they differ.

Australian prescription status and our ordering policy

Ropinirole is a Prescription Only Medicine classified in Schedule 4 in Australia. This means it must be prescribed by an authorised prescriber for lawful supply. The regulatory classification is set under Australian medicines law and is separate from our website's ordering process.

Under our current ordering policy, we do not ask customers to submit a prescription during checkout. That administrative policy does not change ropinirole's Schedule 4 status, replace consultation with a prescriber or authorise anyone to use the medicine without appropriate medical direction. Customers should have their prescribed strength and directions available before choosing an option from our catalogue.

The registration of a particular Requip strength, package and sponsor can be checked in the Australian Register of Therapeutic Goods. Product registration and any Pharmaceutical Benefits Scheme eligibility are separate from the prices and ordering options we present on this page.

How does our ordering process work?

After confirming the prescribed strength, select one of the package quantities we list and review the current total and unit value. Before completing our checkout, check the product name, strength, quantity, customer details and Australian delivery postcode carefully. Do not rely on tablet colour or appearance alone, as these features can vary between products and manufacturers.

1. Select the exact Requip strength directed by the prescriber.
2. Compare only the package quantities available from us for that strength.
3. Review the order summary and any delivery information presented during our checkout before confirming the order.
4. Provide complete recipient and address details, including the correct postcode.
5. After we accept the order, we prepare it for dispatch in line with the information provided during checkout.

We do not state a delivery time or charge unless it is shown as part of the current order process. Our support team is available 24 hours a day, seven days a week by email and online chat. A pharmacist is also available if a question concerns the medicine rather than the mechanics of placing an order.

When the parcel arrives, check the medicine name, strength, quantity, packaging condition and expiry date before taking a tablet. If the supplied item appears incorrect or damaged, do not use it; contact our support team so we can review the order.

Value without unnecessary quantity

The most useful comparison combines the prescribed strength, a realistic package quantity and the current price rather than focusing on the lowest unit cost alone. Larger packages may provide better unit value, but they can be unsuitable when treatment has just started, the dose is changing or the tablets may not be used before expiry.

Start with the strength and directions provided by the prescriber, then use our package-value comparison to assess the quantities and prices available for that exact strength. This keeps the clinical decision separate from the purchasing decision while still making it possible to identify practical value. If the treatment instructions are uncertain, clarification from a prescriber or pharmacist is more important than choosing a package immediately.